Dr. Furie is usually Chief of the Division of Rheumatology, Hofstra North Shore LIJ College of Medicine, Great Neck, New York. The abstract happens to be available on the ACR website. We are pleased that Dr. Furie will talk about the first results of our pilot study on the consequences of Acthar in sufferers with this complicated disease at the upcoming ACR Annual Meeting, stated Steven Romano, M.D., Senior Vice Chief and President Scientific Officer of Mallinckrodt. Mallinckrodt is focused on completing this essential clinical study to look for the great things about Acthar for lupus patients who often have exhausted other great therapeutic options because of this difficult-to-treat condition. .. Clinical study data in Mallinckrodt’s H.P. Acthar Gel to be offered at ACR 2015 Mallinckrodt plc , a respected specialty biopharmaceutical company, today declared that data from a pilot study because of its H.P.‘We anticipate that the strain we’ve developed will be utilized in a scientific trial in 2013 led by Jan Theys and Philippe Lambin at the University of Maastricht in The Netherlands. A successful outcome may lead to its adoption as a frontline therapy for treating solid tumors.’ To find out more:.. Blog examines effect of adolescent pregnancy in South Asia Within its monthly series Tales Behind the Figures, ‘guest edited by FHI 360 with respect to USAID’S IYWG, which gives technical leadership to boost the sexual and reproductive health of teenagers,’ the Costs & Melinda Gates Foundation’s ‘Impatient Optimists’ blog includes a tale by Gaj Bahadur Gurung, program coordinator for the National Federation of Women Coping with HIV and Supports Nepal, who discusses the impact of adolescent pregnancy on girls and youthful women in Southern Asia.